Walgreen to pay more than $2.85 million to settle US overbilling charges-February 2024-www.financetom.com

Walgreen to pay more than $2.85 million to settle US overbilling charges

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Walgreen to pay more than $2.85 million to settle US overbilling charges

Mar 27, 2025 10:42 AM

(Reuters) -Walgreen will pay more than $2.85 million to settle whistleblower allegations that the pharmacy overbilled Medicaid programs in Georgia and Massachusetts for generic medications, the U.S. Department of Justice said on Thursday.

The settlement partially resolves claims against the Walgreens Boots Alliance ( WBA ) unit brought under the federal, Georgia and Massachusetts False Claims Act.

Walgreen pharmacies were accused of having from 2008 to 2023 submitted elevated "usual and customary" prices for some generic medications to the MassHealth and Georgia Medicaid programs, causing those programs to pay more for the medications than they should have.

(Reporting by Jonathan Stempel in New York)

Previous page： FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves Next page： Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves

Oct 17, 2024

Novavax Inc. ( NVAX ) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination (CIC) and stand-alone influenza vaccine candidates. The clinical hold is due to a spontaneous report of a serious adverse event (SAE) of motor neuropathy in a single CIC Phase 2 trial participant outside...

Novavax's COVID-19-Influenza Vaccine Trial Put on Clinical Hold, Shares Fall

Oct 17, 2024

09:18 AM EDT, 10/16/2024 (MT Newswires) -- Novavax ( NVAX ) said Wednesday that the US Food and Drug Administration has placed a clinical hold on its investigational new drug application for its COVID-19-influenza combination and standalone influenza vaccine candidates. The company said the clinical hold is due to a report of a serious adverse event involving motor neuropathy in...

ASML's early earnings publication a 'human mistake', shareholder group says

Oct 17, 2024

AMSTERDAM (Reuters) - A group of Dutch shareholders on Wednesday reacted with dismay to chip equipment maker's ASML's accidental early publication of its third-quarter earnings, but were also sympathetic to what they called a human mistake. For a company which is the largest listed company in the Netherlands and also the leading technology company in Europe ... it is not...

Logistics Real Estate Company Prologis' Q3 Earnings: FFO Beats, Revenue Misses, Revises FY24 Guidance

Oct 17, 2024

Prologis, Inc. ( PLD ) shares are trading higher after the company reported third-quarter financial results. Rental revenue of $1.90 billion missed the consensus estimates of $1.95 billion. The company’s average occupancy stood at 95.9%, with a leased 49.0MSF operating portfolio and a 1.8MSF development portfolio. Core funds from operations per diluted share were $1.43, higher than $1.30 a year ago and above the consensus of $1.37. During the quarter,...